{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:42:45Z","timestamp":1785220965850,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.antiviral.2008.01.154","type":"journal-article","created":{"date-parts":[[2008,2,25]],"date-time":"2008-02-25T16:32:41Z","timestamp":1203957161000},"page":"49-61","source":"Crossref","is-referenced-by-count":77,"title":["Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo"],"prefix":"10.1016","volume":"79","author":[{"given":"Mark","family":"Schleiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Eickhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Auerochs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Leis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Abele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Rechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rawlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ensminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Klebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stamminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2008.01.154_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.virol.2004.03.015","article-title":"Phosphorylation of the RNA polymerase II carboxyl-terminal domain in human cytomegalovirus-infected cells and in vitro by the viral UL97 protein kinase","volume":"324","author":"Baek","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.01.154_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpharm.2007.04.002","article-title":"Pharmacokinetics of gefitinib in humans: the influence of gastrointestinal factors","volume":"341","author":"Bergman","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.antiviral.2008.01.154_bib3","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1073\/pnas.83.22.8769","article-title":"A human cytomegalovirus mutant resistant to the nucleoside analog 9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}guanine (BW B759U) induces reduced levels of BW B759U triphosphate","volume":"83","author":"Biron","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2008.01.154_bib4","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/AAC.46.8.2365-2372.2002","article-title":"Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole l-riboside with a unique mode of action","volume":"46","author":"Biron","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.154_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/0008-5472.379.65.2","article-title":"Cellular targets of gefitinib","volume":"65","author":"Brehmer","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2008.01.154_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00126839-200607020-00002","article-title":"Strategies to overcome resistance to targeted protein kinase inhibitors in the treatment of cancer","volume":"7","author":"Buschbeck","year":"2006","journal-title":"Drugs R D"},{"key":"10.1016\/j.antiviral.2008.01.154_bib7","first-page":"53","article-title":"Assessing and managing toxicities induced by kinase inhibitors","volume":"10","author":"Castoldi","year":"2007","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"10.1016\/j.antiviral.2008.01.154_bib8","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1128\/JVI.78.13.7124-7130.2004","article-title":"Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir","volume":"78","author":"Chou","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.154_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1086\/518514","article-title":"Cytomegalovirus UL97 kinase mutations that confer maribavir resistance","volume":"196","author":"Chou","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.154_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1634\/theoncologist.8-4-303","article-title":"FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets","volume":"8","author":"Cohen","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.antiviral.2008.01.154_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0966-842X(00)01699-1","article-title":"Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus","volume":"8","author":"Fortunato","year":"2000","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2008.01.154_bib12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nrc1506","article-title":"Gefitinib\u2014a novel targeted approach to treating cancer","volume":"4","author":"Herbst","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.antiviral.2008.01.154_bib13","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1097\/01.aids.0000194805.74293.11","article-title":"Indirubin-3\u2032-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication","volume":"19","author":"Heredia","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2008.01.154_bib14","series-title":"New Concepts of Antiviral Therapy","first-page":"351","article-title":"Recent developments in anti-herpesviral combination therapy based on protein kinase inhibitors","author":"Herget","year":"2006"},{"key":"10.1016\/j.antiviral.2008.01.154_bib15","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/AAC.48.11.4154-4162.2004","article-title":"A novel chemical class of pUL97 protein kinase-specific inhibitors with strong anti-cytomegaloviral activity","volume":"48","author":"Herget","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.154_bib16","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1128\/JVI.00169-07","article-title":"Epidermal growth factor is not required for human cytomegalovirus entry or signaling","volume":"81","author":"Isaacson","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.154_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2005.10.003","article-title":"The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo","volume":"69","author":"Kaptein","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2008.01.154_bib18","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JVI.77.4.2359-2368.2003","article-title":"Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta","volume":"77","author":"Kawaguchi","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.154_bib19","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.46.8.2373-2380.2002","article-title":"Preclinical and toxicology studies of 1263W94, a potent and selective inhibitor of human cytomegalovirus replication","volume":"46","author":"Koszalka","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.154_bib20","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1128\/JVI.77.14.7720-7727.2003","article-title":"The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase","volume":"77","author":"Krosky","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.154_bib21","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1128\/AAC.46.9.2969-2976.2002","article-title":"Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding","volume":"46","author":"Lalezari","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.154_bib22","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/AAC.44.6.1588-1597.2000","article-title":"Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents","volume":"44","author":"Marschall","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.154_bib23","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1099\/0022-1317-82-6-1439","article-title":"Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97","volume":"82","author":"Marschall","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2008.01.154_bib24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1099\/0022-1317-83-5-1013","article-title":"Direct targeting of human cytomegalovirus protein kinase pUL97 by kinase inhibitors is a novel principle for antiviral therapy","volume":"83","author":"Marschall","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2008.01.154_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0042-6822(03)00147-8","article-title":"The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44","volume":"311","author":"Marschall","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.01.154_bib26","doi-asserted-by":"crossref","first-page":"33357","DOI":"10.1074\/jbc.M502672200","article-title":"Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina","volume":"280","author":"Marschall","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2008.01.154_bib27","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1086\/368094","article-title":"Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation","volume":"187","author":"Mathys","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.01.154_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/mgme.2000.3102","article-title":"Molecular cloning of the guinea pig cytomegalovirus (GPCMV) genome as an infectious bacterial artificial chromosome (BAC) in Escherichia coli","volume":"72","author":"McGregor","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.antiviral.2008.01.154_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1087057104270269","article-title":"Identification of inhibitors for a virally encoded protein kinase by 2 different screening systems: in vitro kinase assay and in-cell activity assay","volume":"10","author":"Mett","year":"2005","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.antiviral.2008.01.154_bib30","series-title":"Fields Virology","first-page":"2701","article-title":"Cytomegaloviruses","author":"Mocarski","year":"2007"},{"key":"10.1016\/j.antiviral.2008.01.154_bib31","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1158\/1078-0432.CCR-06-0646","article-title":"Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs","volume":"12","author":"Ono","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.antiviral.2008.01.154_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.antiviral.2006.06.004","article-title":"Antiviral activity of arthrospira-derived spirulan-like substances","volume":"7","author":"Rechter","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2008.01.154_bib33","doi-asserted-by":"crossref","first-page":"7044","DOI":"10.1021\/jm060696s","article-title":"Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation","volume":"49","author":"Romaker","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2008.01.154_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/095632020601700601","article-title":"Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs","volume":"17","author":"Schang","year":"2006","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2008.01.154_bib35","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1099\/vir.0.80910-0","article-title":"Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus","volume":"86","author":"Scott","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2008.01.154_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/154065804323056549","article-title":"Immobilized metal ion affinity-based fluorescence polarization (IMAP): advances in kinase screening","volume":"2","author":"Sportsman","year":"2004","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.antiviral.2008.01.154_bib37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/358162a0","article-title":"A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells","volume":"358","author":"Sullivan","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.154_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/AAC.37.1.19","article-title":"A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives","volume":"37","author":"Sullivan","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.154_bib39","doi-asserted-by":"crossref","first-page":"10729","DOI":"10.1128\/JVI.74.22.10729-10736.2000","article-title":"Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity","volume":"74","author":"Wagner","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.01.154_bib40","first-page":"5749","article-title":"ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy","volume":"62","author":"Wakeling","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2008.01.154_bib41","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/AAC.47.4.1334-1342.2003","article-title":"Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects","volume":"47","author":"Wang","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.154_bib42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nature01818","article-title":"Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus","volume":"424","author":"Wang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2008.01.154_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0166-3542(00)00118-2","article-title":"Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase","volume":"48","author":"Zimmermann","year":"2000","journal-title":"Antiviral Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208002015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208002015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T16:54:13Z","timestamp":1684256053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354208002015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0166354208002015"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2008.01.154","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}